delaying disease progression in early, non-metastatic crpc treatment
Published 5 years ago • 71 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
0:42
enzalutamide in the non-metastatic setting for crpc
-
1:22
advances in non-metastatic castration-resistant prostate cancer
-
2:49
treating oligometastatic crpc with radiation to delay hormonal therapy
-
22:16
understanding non metastatic castration resistant prostate cancer with dr. hamilton
-
5:52
clinical trials in non-metastatic crpc
-
6:51
understanding nonmetastatic crpc: an overview
-
3:19
live long and prosper: enzalutamide for nmcrpc
-
1:45
dr. choudhury on antiandrogen treatment selection in nonmetastatic crpc
-
4:41
darolutamide’s role in treating nonmetastatic crpc
-
4:36
nonmetastatic crpc: considerations for apalutamide
-
8:47
treatment of metastatic crpc
-
2:27
how will new nsaas impact clinical practice in prostate cancer?
-
1:19
nonmetastatic crpc: meeting an unmet need
-
2:47
enzamet trial: early enzalutamide delays progression, improves survival in mhspc
-
1:10
treatment options for patients with metastatic castration-resistant prostate cancer
-
22:03
treatment advances in non-metastatic castration-resistent prostate cancer (nmcrpc)
-
13:46
timing and optimization of radium 223 in castration resistant prostate cancer
-
39:15
aua: sequencing of agents and combination therapy in castrate resistant prostate cancer
-
5:33
improvements in detecting and treating metastatic crpc